Use of tegaserod along with polyethylene glycol electrolyte solution for colonoscopy bowel preparation: A prospective, randomized, double-blind, placebo-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 5, 2006, Pages 669-674

  Sanaka, M R ^a   Super, D M ^a   Mullen, K D ^a   Ferguson, D R ^a   McCullough, A J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; MACROGOL; PLACEBO; TEGASEROD;

ABDOMINAL PAIN; ADULT; AGED; ANAL COMPLAINT; ARTICLE; BLOATING; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; FEMALE; HUMAN; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA AND VOMITING; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

COLON; COLONOSCOPY; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INDOLES; MALE; MIDDLE AGED; PATIENT SATISFACTION; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SOLUTIONS; SURFACE-ACTIVE AGENTS;

EID: 33645013640     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02790.x     Document Type: Article

References (28)

1. Davis GR Santa Ana CA Morawski SG Fordtran JS Development of a lavage solution associated with minimal water and electrolyte absorption or secretion Gastroenterology 1980 78 991 5
2. Vanner SJ MacDonald PH Paterson WG Prentice RS DaCosta LR Beck IT A randomized prospective trial comparing oral sodium phosphate with standard polyethylene glycol-based lavage solution (Golytely) in the preparation of patients for colonoscopy Am J Gastroenterol 1990 85 422 7
3. Kolts BE Lyles WE Achem SR Burton L Geller AJ MacMath T A comparison of the effectiveness and patient tolerance of oral sodium phosphate, castor oil, and standard electrolyte lavage for colonoscopy or sigmoidoscopy preparation Am J Gastroenterol 1993 88 1218 23
4. Cohen SM Wexner SD Binderow SR et al. Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods Dis Colon Rectum 1994 37 689 96
5. Frommer D Cleansing ability and tolerance of three bowel preparations for colonoscopy Dis Colon Rectum 1997 40 100 4
6. Marshall JB Pineda JJ Barthel JS King PD Prospective, randomized trial comparing sodium phosphate solution with polyethylene glycol-electrolyte lavage for colonoscopy preparation Gastrointest Endosc 1993 39 631 4
7. Golub RW Kerner BA Wise WE Jr. et al. Colonoscopic bowel preparations - which one? A blinded, prospective, randomized trial Dis Colon Rectum 1995 38 594 9
8. Afridi SA Barthel JS King PD Pineda JJ Marshall JB Prospective, randomized trial comparing a new sodium phosphate-bisacodyl regimen with conventional PEG-ES lavage for outpatient colonoscopy preparation Gastrointest Endosc 1995 41 485 9
9. Thomson A Naidoo P Crotty B Bowel preparation for colonoscopy: a randomized prospective trial comparing sodium phosphate and polyethylene glycol in a predominantly elderly population J Gastroenterol Hepatol 1996 11 103 7
10. Oliveira L Wexner SD Daniel N et al. Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions Dis Colon Rectum 1997 40 585 91
11. Clarkston WK Tsen TN Dies DF Schratz CL Vaswani SK Bjerregaard P Oral sodium phosphate vs. sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison Gastrointest Endosc 1996 43 42 8
12. Pontone P Bogliolo G Pietropaolo V Pallotto P Polyethylene glycol vs. sodium phosphate: comparison of 2 preparations for colonoscopy G Chir 1996 17 128 31
13. Marshall JB Barthel JS King PD Short report: prospective, randomized trial comparing a single dose sodium phosphate regimen with PEG-electrolyte lavage for colonoscopy preparation Aliment Pharmacol Ther 1993 7 679 82
14. Henderson JM Barnett JL Turgeon DK et al. Single-day, divided-dose oral sodium phosphate laxative vs. intestinal lavage as preparation for colonoscopy: efficacy and patient tolerance Gastrointest Endosc 1995 42 238 43
15. Toledo TK DiPalma JA Colon cleansing preparation for gastrointestinal procedures Alimentary Pharmacol Ther 2001 15 605 11
16. Ueda S Iishi H Tatsuta M Oda K Osaka S Addition of cisapride shortens colonoscopy preparation with lavage in elderly patients Aliment Pharmacol Ther 1994 8 209 14
17. Reiser JR Rosman AS Rajendran SK Berner JS Korsten MA The effects of cisapride on the quality and tolerance of colonic lavage: a double-blind randomized study Gastrointest Endosc 1995 41 481 4
18. Lazarczyk DA Stein AD Courval JM Desai D Controlled study of cisapride-assisted lavage preparatory to colonoscopy Gastrointest Endosc 1998 48 44 8
19. Katsinelos P Pilpilidis I Paroutoglou G et al. The administration of cisapride as an adjuvant to PEG-electrolyte solution for colonic cleansing: a double-blind randomized study Hepatogastroenterology. 2005 52 441 3
20. Martinek J Hess J Delarive J et al. Cisapride does not improve precolonoscopy bowel preparation with either sodium phosphate or polyethylene glycol electrolyte lavage Gastrointest Endosc 2001 54 180 5
21. Degen LP Matzinger D Merz M et al. Tegaserod (HTF 919) a 5-HT4 receptor agonist accelerates gastrointestinal (GI) tract Neurogastroenterol Motil 2000 12 382
22. Prather CM Camilleri M Zinmeister AR McKinzie S Thomforde G Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome Gastroenterology 2000 118 463 8
23. Degen L Matzinger D Merz M et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects Alimentary Pharmacol Ther 2001 15 1745 51
24. Tougas G Snape WJ Jr. Otten MH et al. Long-term safety of tegaserod in patients with constipation predominant irritable bowel syndrome Alimentary Pharmacol Ther 2002 16 1701 8
25. Fidelholtz J Smith W Rawls J et al. Safety and tolerability of Tegaserod in patients with Irritable Bowel Syndrome and Diarrhea symptoms Am J Gastroenterol 2002 97 1176 81
26. Morganroth J Ruegg PC Dunger-Baldauf C et al. Tegaserod, a 5-Hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effecs Am J Gastroenterol 2002 97 2321 27
27. Kamm MA Muller-Lissner S Talley NJ et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study Am J Gastroenterol 2005 100 362 72
28. Matter SE Rice PS Campbell DR Colonic lavage solutions: plain vs. flavored Am J Gastroenterol 1993 88 49 52